Europe, Astrazeneca, Vaccines, Covıd-19

Europe, Astrazeneca

EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

7/5/2021 4:01:00 PM

EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

Europe 's medicines regulator said on Friday it was reviewing reports of a rare nerve-degenerating disorder in people who have received ...

BookmarkAMSTERDAM: Europe's medicines regulator said on Friday (May 7) it was reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZeneca's COVID-19 vaccine, and requested more detailed data on the cases from the company.

They relied on Chinese vaccines. Now they’re battling outbreaks Jail and fine for man who dragged, hit girlfriend outside Sentosa beach club in ‘prolonged and savage’ assault Singapore to increase spending on ICT to S$3.8 billion; more projects for SMEs

As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agency's safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.AdvertisementAdvertisement Read more: CNA »

McDonald's BTS Meal Sells Out In 5 Mins; No BTS Logo Paper Bag

AZ should be ban ... too many cases Dont know from where EU regulators comes up with such reports?